Cytokinetics Inc (CYTK)
65.92
+0.87
(+1.34%)
USD |
NASDAQ |
May 07, 12:14
Cytokinetics Gross Profit (Quarterly): -83.30M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -83.30M |
September 30, 2023 | -82.15M |
June 30, 2023 | -82.33M |
March 31, 2023 | -74.81M |
December 31, 2022 | -73.06M |
September 30, 2022 | -60.22M |
June 30, 2022 | 31.84M |
March 31, 2022 | -44.79M |
December 31, 2021 | 12.10M |
September 30, 2021 | -43.00M |
June 30, 2021 | -33.60M |
March 31, 2021 | -25.01M |
December 31, 2020 | -22.50M |
September 30, 2020 | 17.49M |
June 30, 2020 | -18.20M |
March 31, 2020 | -17.91M |
December 31, 2019 | -13.12M |
September 30, 2019 | -14.17M |
June 30, 2019 | -16.88M |
March 31, 2019 | -15.08M |
December 31, 2018 | -13.90M |
September 30, 2018 | -10.75M |
June 30, 2018 | -15.37M |
March 31, 2018 | -16.87M |
December 31, 2017 | -26.27M |
Date | Value |
---|---|
September 30, 2017 | -18.77M |
June 30, 2017 | -16.76M |
March 31, 2017 | -15.14M |
December 31, 2016 | 14.36M |
September 30, 2016 | 41.18M |
June 30, 2016 | -3.921M |
March 31, 2016 | -5.113M |
December 31, 2015 | -3.492M |
September 30, 2015 | -3.612M |
June 30, 2015 | -6.094M |
March 31, 2015 | -4.542M |
December 31, 2014 | 12.98M |
September 30, 2014 | -2.005M |
June 30, 2014 | -3.949M |
March 31, 2014 | -4.511M |
December 31, 2013 | 10.52M |
September 30, 2013 | -8.976M |
June 30, 2013 | -11.34M |
March 31, 2013 | -9.013M |
December 31, 2012 | -7.674M |
September 30, 2012 | -7.084M |
June 30, 2012 | -6.401M |
March 31, 2012 | -6.925M |
December 31, 2011 | -36.42M |
September 30, 2011 | 1.427M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-83.30M
Minimum
Dec 2023
31.84M
Maximum
Jun 2022
-33.88M
Average
-25.01M
Median
Mar 2021
Gross Profit (Quarterly) Benchmarks
Amgen Inc | 4.247B |
Johnson & Johnson | 14.87B |
Eli Lilly and Co | 7.094B |
Viking Therapeutics Inc | -- |
Madrigal Pharmaceuticals Inc | -- |